Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ: EPRX · IEX Real-Time Price · USD

2.520

+0.050 (2.02%)

At close: Jul 2, 2024, 3:57 PM

2.551

+0.031 (1.23%)

After-hours: Jul 2, 2024, 5:02 PM EDT

Eupraxia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	90	-	-
Enterprise Value	63	-9	-9
PB Ratio	4.59	-	-
EV/EBITDA Ratio	-	0.32	0.52
EV/EBIT Ratio	-	0.32	0.52
EV/FCF Ratio	-	0.43	0.63
Debt / Equity Ratio	0.49	4.72	1.15
Debt / EBITDA Ratio	-	-0.38	-0.50
Debt / FCF Ratio	-	-0.50	-0.61
Quick Ratio	1.95	1.01	6.00
Current Ratio	1.95	1.02	6.08
Interest Coverage	-	-23.72	-18.32
Return on Equity (ROE)	-	-579.20%	-
Return on Assets (ROA)	-	-147.10%	-
Return on Capital (ROIC)	-	-219.82%	-105.04%
Buyback Yield / Dilution	-49.40%	-25.21%	-
Total Shareholder Return	-49.40%	-25.21%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).